Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:13 PM
Ignite Modification Date:
2025-12-24 @ 9:13 PM
NCT ID:
NCT05331404
Eligibility Criteria:
Inclusion Criteria:
For presbyacusics subjects:
* Subjects aged over 50 with a difference in symmetrical audiometric thresholds (\< 15 dB) between the two ears and requiring hearing aids
* Affiliation to a social security scheme or equivalent
* Acceptance of the protocol and signature of the consent form
For older people with normal hearing:
* Subjects matched in age (+/- 2 years) and gender with the presbycusis group
* Affiliation to a social security scheme or equivalent
* Acceptance of the protocol and signature of the consent form
* Subjects with normal hearing, with hearing thresholds of 20 dB \< 2kHz and 40 dB \< 4kHz
For young people with normal hearing:
* Subjects aged between 18 and 40 years old,
* Symmetric normal hearing
* Affiliation to a social security scheme or equivalent
* Normally hearing subjects with audiometric thresholds \< 20 dB
* Acceptance of the protocol and signature of the consent form
Exclusion Criteria:
* Persons under a legal protection regime for adults (safeguard of justice, guardianship, curator ship, institutionalized, or under mandate for future protection)
* History of associated neurological pathology
* Contraindications to PET
* Cognitive impairment confirmed by the Montreal Cognitive Assessment (MOCA) test (for presbyacusic subjects and normal-hearing elderly subjects)
* Taking psychotropic drugs
* History of epilepsy
* Pregnant or breastfeeding woman
* Participation in another intervention protocol
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05331404
Study Brief:
Protocol Section:
NCT05331404